Sandoz CEO calls out Trump tariffs; Wegovy trial shows promise for children under 12; Access issues emerge for Revolution ...

Connecting insight, communications and healthcare experience . In this episode, Greg Novello, managing director of Spherico, ...

CEO Jeff Green said the job cuts are about preparing for growth, not financial trouble, as the adtech giant revealed a $1.5bn ...

Every day, 6,000 women in the U.S. enter menopause . More than 1 billion women globally are living through this transition ...

PHM Verified will score media products based on the quality of their HCP identity and engagement data as the agency seeks to bring greater transparency to the market.

The FDA’s Office of Prescription Drug Promotion sent Travere Therapeutics a letter over its advertising for Filspari, a drug that’s approved to slow kidney function decline in people with primary IgA ...

MM+M launched the 2026 Career and Salary Survey on Tuesday morning. Now in its 40th year, the Career and Salary Survey serves ...

What to learn from the cancer vaccines; Naloxone and harm reduction practices make a dent in overdose deaths; RFK Jr. in ...

ARPA-H announced it will grant up to $125 million to projects aimed at accelerating the manufacturing of custom RNA-based ...

The agency said booth materials for Alar’s investigational ALA-3000 made unsupported safety and efficacy claims and failed to ...

FDA further tests waters on AI medical devices; Ultragenyx sees its stock crater on Phase 3 trial failure; Brain implants ...

A major MFN pricing loophole; An uptick in parents opting out of vitamin K shots for newborns; BI leans into AI-powered drug ...